Columbus Circle Investors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Columbus Circle Investors's CELG Position: Q4 2017 in Review
Columbus Circle Investors sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 575,542 shares — an estimated $82.3M sold.
Columbus Circle Investors first reported a position in CELG in Q2 2013 and held it in 16 quarters. The position peaked at $121M in Q4 2016. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.
- Columbus Circle Investors reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
- Columbus Circle Investors sold 575,542 Celgene Corp shares in Q4 2017, an estimated $82.3M.
- Columbus Circle Investors first reported a position in Celgene Corp in Q2 2013 and held it in 16 quarters.
- Columbus Circle Investors's Celgene Corp position peaked at $121M in Q4 2016.
- 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.
Based on Columbus Circle Investors's 13F filing for Q4 2017, filed 2 Feb 2018.